Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07636590 · ClinicalTrials.gov registry record
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A clinical trial, sponsored by Claris Biotherapeutics.
- Recruiting
- Registry status
- 500
- Enrollment target
NCT07636590: Recruiting study, sponsored by Claris Biotherapeutics.
NCT07636590 is a clinical trial that is actively recruiting participants, run by Claris Biotherapeutics. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07636590 is actively recruiting participants, sponsored by Claris Biotherapeutics.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
Study Summary
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
Primary Outcome
Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires
Interventions
- OTHER Non-interventional
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-05-22 |
| Est. Completion | 2028-03 |
What NCT07636590 shows while recruiting
NCT07636590 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non-interventional is the first listed.
NCT07636590 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07636590 about?
NCT07636590 is a clinical study titled "Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency". The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
What is the current status of trial NCT07636590?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2026-05-22. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07636590?
The interventions under investigation include: Non-interventional (OTHER).
Who is sponsoring clinical trial NCT07636590?
This trial is sponsored by Claris Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI